SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003043
Filing Date
2021-03-16
Accepted
2021-03-16 08:30:48
Documents
92
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K akro-20201231x10k.htm 10-K 2022241
2 EX-21.1 akro-20201231ex211384978.htm EX-21.1 4911
3 EX-23.1 akro-20201231ex231dba57d.htm EX-23.1 1997
4 EX-31.1 akro-20201231ex3113fca1e.htm EX-31.1 19132
5 EX-31.2 akro-20201231ex3124af347.htm EX-31.2 19386
6 EX-32.1 akro-20201231ex321492868.htm EX-32.1 11457
7 GRAPHIC akro-20201231x10k001.jpg GRAPHIC 20578
8 GRAPHIC akro-20201231x10k002.jpg GRAPHIC 25117
9 GRAPHIC akro-20201231x10k003.jpg GRAPHIC 51207
10 GRAPHIC akro-20201231x10k004.jpg GRAPHIC 40972
11 GRAPHIC akro-20201231x10k005.jpg GRAPHIC 19040
12 GRAPHIC akro-20201231x10k006.jpg GRAPHIC 24714
13 GRAPHIC akro-20201231x10k007.jpg GRAPHIC 23146
14 GRAPHIC akro-20201231x10k008.jpg GRAPHIC 26092
15 GRAPHIC akro-20201231x10k009.jpg GRAPHIC 27466
16 GRAPHIC akro-20201231x10k010.jpg GRAPHIC 31075
17 GRAPHIC akro-20201231x10k011.jpg GRAPHIC 38484
  Complete submission text file 0001558370-21-003043.txt   8126403

Data Files

Seq Description Document Type Size
18 EX-101.INS akro-20201231.xml EX-101.INS 1594162
19 EX-101.SCH akro-20201231.xsd EX-101.SCH 54683
20 EX-101.CAL akro-20201231_cal.xml EX-101.CAL 52280
21 EX-101.DEF akro-20201231_def.xml EX-101.DEF 150199
22 EX-101.LAB akro-20201231_lab.xml EX-101.LAB 520162
23 EX-101.PRE akro-20201231_pre.xml EX-101.PRE 381633
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38944 | Film No.: 21743732
SIC: 2834 Pharmaceutical Preparations